Nicola Scopinaro1, Gian Franco Adami2,3, Paolo Bruzzi4, Renzo Cordera5,6. 1. Department of Surgery, IRCCS San Martino and Università di Genova, Genoa, Italy. 2. Department of Endocrinology, IRCCS San Martino and Università di Genova, Genoa, Italy. adami@unige.it. 3. Department of Internal Medicine, University of Genova, Viale Benedetto XV, 8, 15132, Genoa, Italy. adami@unige.it. 4. Department of Statistics, IRCCS San Martino and Università di Genova, Genoa, Italy. 5. Department of Endocrinology, IRCCS San Martino and Università di Genova, Genoa, Italy. 6. Department of Internal Medicine, University of Genova, Viale Benedetto XV, 8, 15132, Genoa, Italy.
Abstract
IMPORTANCE: In obese patients with type 2 diabetes (T2DM), the marked weight loss following bariatric surgery is accompanied in a consistent number of cases by T2DM resolution or control. The clinical need of preoperative parameters reliable in predicting a positive metabolic outcome at long term following the operation has then emerged. OBSERVATION: A cohort of 135 consecutive T2DM patients with a wide range of body mass index (BMI) at more than 5 years following biliopancreatic diversion (BPD) was considered. The 5-year-T2DM resolution, defined as glycosylated hemoglobin (HbA1C) lower than 6.5% without antidiabetic therapy, was related to demographic, anthropometric, and biochemical findings prior to the operation. The long-term metabolic outcome was positively related to baseline BMI values and negatively with the preoperative use of insulin. CONCLUSION: BMI and insulin therapy at the time of surgery are associated with the probability of T2DM long lasting remission and could be used as solid predictors before surgery. In the overweight and non morbidly obese diabetic patients, bariatric surgery is less efficient in determining long term T2DM resolution than in their morbid obese counterparts.
IMPORTANCE: In obesepatients with type 2 diabetes (T2DM), the marked weight loss following bariatric surgery is accompanied in a consistent number of cases by T2DM resolution or control. The clinical need of preoperative parameters reliable in predicting a positive metabolic outcome at long term following the operation has then emerged. OBSERVATION: A cohort of 135 consecutive T2DM patients with a wide range of body mass index (BMI) at more than 5 years following biliopancreatic diversion (BPD) was considered. The 5-year-T2DM resolution, defined as glycosylated hemoglobin (HbA1C) lower than 6.5% without antidiabetic therapy, was related to demographic, anthropometric, and biochemical findings prior to the operation. The long-term metabolic outcome was positively related to baseline BMI values and negatively with the preoperative use of insulin. CONCLUSION: BMI and insulin therapy at the time of surgery are associated with the probability of T2DM long lasting remission and could be used as solid predictors before surgery. In the overweight and non morbidly obese diabeticpatients, bariatric surgery is less efficient in determining long term T2DM resolution than in their morbid obese counterparts.
Entities:
Keywords:
Baritatric surgery; Obesity; Type 2 diabetes
Authors: Beat P Müller-Stich; Jonas D Senft; René Warschkow; Hannes G Kenngott; Adrian T Billeter; Gianmatteo Vit; Stefanie Helfert; Markus K Diener; Lars Fischer; Markus W Büchler; Peter P Nawroth Journal: Ann Surg Date: 2015-03 Impact factor: 12.969
Authors: Simona Panunzi; Lena Carlsson; Andrea De Gaetano; Markku Peltonen; Toni Rice; Lars Sjöström; Geltrude Mingrone; John B Dixon Journal: Diabetes Care Date: 2015-12-01 Impact factor: 19.112
Authors: Maria E Valera-Mora; Benedetta Simeoni; Lucilla Gagliardi; Antonino Scarfone; Giuseppe Nanni; Marco Castagneto; Melania Manco; Geltrude Mingrone; Ele Ferrannini Journal: Am J Clin Nutr Date: 2005-06 Impact factor: 7.045
Authors: Nicola Scopinaro; Giovanni F Adami; Francesco S Papadia; Giovanni Camerini; Flavia Carlini; Martin Fried; Lucia Briatore; Gabriele D'Alessandro; Gabriella Andraghetti; Renzo Cordera Journal: Ann Surg Date: 2011-04 Impact factor: 12.969
Authors: N Scopinaro; G F Adami; G M Marinari; E Gianetta; E Traverso; D Friedman; G Camerini; G Baschieri; A Simonelli Journal: World J Surg Date: 1998-09 Impact factor: 3.352
Authors: John B Buse; Sonia Caprio; William T Cefalu; Antonio Ceriello; Stefano Del Prato; Silvio E Inzucchi; Sue McLaughlin; Gordon L Phillips; R Paul Robertson; Francesco Rubino; Richard Kahn; M Sue Kirkman Journal: Diabetes Care Date: 2009-11 Impact factor: 19.112
Authors: Henry Buchwald; Rhonda Estok; Kyle Fahrbach; Deirdre Banel; Michael D Jensen; Walter J Pories; John P Bantle; Isabella Sledge Journal: Am J Med Date: 2009-03 Impact factor: 4.965